Nuvama Wealth Management Limited (NUVAMA.BO)
BSE · INR · Financial Services · Asset Management
₹1,688.25 (+1.64%) as of
Key statistics
- Market cap
- 311.51B
- P/E (TTM)
- 29.11
- Forward P/E
- 20.16
- EPS (TTM)
- 57.99
- Dividend yield
- 1.69%
- 52-week range
- 1,097.25 – 2,067.00
- Beta
- 0.40
- Revenue (TTM)
- 38.53B
- Profit margin
- 28.11%
- Analyst target
- ₹2,038.33
- Volume
- 6.86k
About Nuvama Wealth Management Limited
Nuvama Wealth Management Limited engages in wealth management, asset management and services, and capital markets businesses in India and internationally. It operates through wealth management, asset management, and capital markets segments. The company offers financial products, investment advisory, lending against securities and securities broking services; investment management services for alternative investment funds; and portfolio management services. It is also involved in the institutional broking and merchant banking businesses, as well as provision of advisory and clearing services. The company was formerly known as Edelweiss Securities Limited and changed its name to Nuvama Wealth Management Limited in August 2022. Nuvama Wealth Management Limited was incorporated in 1993 and is based in Mumbai, India. Nuvama Wealth Management Limited operates as a subsidiary of PAGAC Ecstasy Pte. Ltd.
- Sector
- Financial Services
- Industry
- Asset Management
- Headquarters
- Mumbai, India
- Employees
- 3,435
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- 63 Moons Technologies Limited (63MOONS.BO)
- SAKAR HEALTHCARE LIMITED (SAKAR.NS)
- THEJO ENGINEERING LIMITED (THEJO.NS)
- ESPRIT STONES LIMITED (ESPRIT-SM.NS)
- VILAS TRANSCORE LIMITED (VILAS-SM.NS)
- CHOICE INTERNATIONAL LTD. (CHOICEIN.BO)
- NUCLEUS SOFTWARE EXPORTS (NUCLEUS.NS)
- Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)